3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions: The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

3-Year Clinical Follow-Up of the XIENCE V Everolimus-Eluting Coronary Stent System in the Treatment of Patients With De Novo Coronary Artery Lesions: The SPIRIT II Trial (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions)

Authors:	Scot Garg Patrick Serruys Yoshinobu Onuma Cécile Dorange Susan Veldhof Karine Miquel-Hébert Krishnankutty Sudhir Jean Boland Kurt Huber Eulogio Garcia Jan A.M. te Riele

Affiliation:	2. Abbott Vascular, Diegem, Belgium;3. Abbott Vascular, Santa Clara, California;4. C.H.R. La Citadelle, Liege, Belgium;5. University Hospital Gregorio Maranon, Madrid, Spain

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！